Biocom California: Successfully Navigating the USPTO and FDA

Hear from experts from the U.S. Patent and Trademark Office and the Food and Drug Administration about the intricacies biotech and medtech startups face when securing Intellectual Property (IP) rights from the USPTO and seeking regulatory approval from the FDA. Government officials and industry professionals will join the discussion by offering their views and highlighting best practices to help startups with navigating USPTO and FDA procedures.

Meet our Speakers:
USPTO: Jonathan Teixeira Moffat: Director, Medical Devices and Processes
FDA: Dr. Kevin Bugin, Ph.D.: FDA/CDER/Office of New Drugs, Deputy Director for Operations

*For those attendees not residing in Southern California, this event will be live streamed.